Background/aims

The present study examined the relationship between microvascular complications and cognitive decline and the development of structural brain abnormalities over a period of 4 years in patients with type 2 diabetes mellitus (T2DM).

Methods

Sixty-eight elderly patients with T2DM had 2 cognitive assessments with a 4-year interval. Two MRI scans, performed at the same time as the cognitive assessments, were available from 55 patients. Changes in cognitive performance over time were expressed as a regression-based index (RBI). Automated volumetric measurements of total brain, lateral ventricles and white matter hyperintensities were performed. The relationship between baseline microvascular complications [diabetic retinopathy, peripheral neuropathy or albuminuria (micro- or macroalbuminuria)] and cognition and brain volumes was examined with linear regression analyses adjusted for age and sex (for cognition also for IQ).

Results

At baseline, diabetic retinopathy was present in 18% of patients, peripheral neuropathy in 36%, albuminuria in 15%. Retinopathy or neuropathy were not significantly associated with baseline cognition or brain volumes, or changes in these measures over time. Albuminuria was associated with a lower composite RBI score, indicating accelerated cognitive decline (adjusted mean difference between patients with or without albuminuria: -0.58, 95% CI -0.85 to -0.31, p < 0.001).

Conclusion

Albuminuria predicted accelerated cognitive decline in patients with T2DM, but other microvascular complications were unrelated to accelerated cognitive decline or brain MRI abnormalities.

Copyright © 2010 S. Karger AG, Basel.

Overview publication

TitleMicrovascular determinants of cognitive decline and brain volume change in elderly patients with type 2 diabetes.
DateJanuary 1st, 2010
Issue nameDementia and geriatric cognitive disorders
Issue numberv30.5:381-6
DOI10.1159/000321354
PubMed20962529
Authorsde Bresser J, Reijmer YD, van den Berg E, Breedijk MA, Kappelle LJ, Viergever MA & Biessels GJ
InfoUtrecht Diabetic Encephalopathy Study Group, Algra A, van den Berg E, Biessels GJ, Brands AM, Breedijk MA, de Bresser J, Brundel M, van Gijn J, Gispen WH, van der Grond J, de Haan EH, van Huffelen AC, Jongen C, Kappelle LJ, Kessels RP, Mali WP, Manschot SM, Pluim JP, Reijmer YD, Rutten GE, Tiehuis AM, de Valk HW, Viergever MA
Read Read publication